These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 19228224)
1. Clinical guidelines for overactive bladder. Yamaguchi O; Nishizawa O; Takeda M; Yokoyama O; Homma Y; Kakizaki H; Obara K; Gotoh M; Igawa Y; Seki N; Yoshida M; Int J Urol; 2009 Feb; 16(2):126-42. PubMed ID: 19228224 [No Abstract] [Full Text] [Related]
2. The use of botulinum toxin in the treatment of refractory overactive bladder. Mucksavage P; Smith AL; Moy ML Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700 [No Abstract] [Full Text] [Related]
3. Contemporary management of overactive bladder. Smith AL; Wein AJ Postgrad Med; 2012 Jan; 124(1):104-16. PubMed ID: 22314120 [TBL] [Abstract][Full Text] [Related]
4. Nonpharmacologic vs. anticholinergic therapies for overactive bladder. Kripke C Am Fam Physician; 2007 May; 75(9):1336. PubMed ID: 17508527 [No Abstract] [Full Text] [Related]
5. Medical therapy and botulinum toxin in dystonia. Jankovic J Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914 [No Abstract] [Full Text] [Related]
6. Changing treatments for overactive bladder. Waine E; Stott M Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960 [TBL] [Abstract][Full Text] [Related]
7. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Roxburgh C; Cook J; Dublin N Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003190. PubMed ID: 17943782 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin: new option for refractory lower urinary tract symptoms in women. Rickey LM; Kenton K Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512 [TBL] [Abstract][Full Text] [Related]